INTRODUCTION Enhanced recovery programmes have been established in some areas of elective surgery. This study applied enhanced recovery principles to elective oesophageal and gastric cancer surgery. METHODS An enhanced recovery programme for patients undergoing open oesophagogastrectomy, total and subtotal gastrectomy for oesophageal and gastric malignancy was designed. A retrospective cohort study compared length of stay on the critical care unit (CCU), total length of inpatient stay, rates of complications and in-hospital mortality prior to (35 patients) and following (27 patients) implementation. RESULTS In the cohort study, the median total length of stay was reduced by 3 days following oesophagogastrectomy and total gastrectomy. The median length of stay on the CCU remained the same for all patients. The rates of complications and mortality were the same. CONCLUSIONS The standardised protocol reduced the median overall length of stay but did not reduce CCU stay. Enhanced recovery principles can be applied to patients undergoing major oesophagogastrectomy and total gastrectomy as long as they have minimal or reversible co-morbidity. KEYWORDSGastric neoplasms -Oesophageal neoplasms -Surgical procedures -Perioperative careEnhanced recovery Accepted 24 January 2015 CORRESPONDENCE TO Piers Gatenby, E: p.gatenby@ucl.ac.uk Enhanced recovery after surgery (ERAS) or fast track programmes have been well established in elective surgery for colorectal resections and joint replacement.1-6 These programmes benefit patients, healthcare providers and those commissioning healthcare by providing earlier recovery with faster return to normal activity as well as improvement in quality of care, productivity, consistency and patient experience with innovative and efficient multidisciplinary practice. 7 The aim of this study was to examine the approach to and outcomes of the implementation of an ERAS programme in a group of patients admitted for open oesophageal and gastric resections for adenocarcinoma under a single upper gastrointestinal surgeon at a tertiary referral centre. MethodsA retrospective audit was performed of the periods prior to (control group) and following (intervention group) the implementation of an ERAS pathway. The study was undertaken in a specialist cancer centre that serves a population of 1.6 million, receiving over 350 new oesophagogastric referrals, and performing approximately 75 oesophageal and gastric resections annually. All patients involved in the study were under the care of a single oesophagogastric surgeon (WHA). The control cohort consisted of all patients undergoing surgery between 1 January and 31 December 2009. The intervention was then implemented over a three-month period and the intervention cohort comprised all patients from 1 April 2010 to 31 March 2011. Demographic data on age and sex, and use of preoperative chemotherapy were recorded.Following the introduction of the intervention, all patients who were fit enough for surgery proceeded along the ERAS pathway as the default...
No abstract
Paediatric multisystem inflammatory syndrome: temporally associated with SARS-COV-2 (PIMS-TS) is a well described rare but severe COVID-19 related syndrome. PIMS-TS have been reported in children from geographical areas of high COVID-19 infection. Most children with PIMS-TS require management in an intensive care unit with variable respiratory involvement. Adults recovering from COVID-19 infection have been reported to suffer from respiratory morbidity but such outcomes are unknown in children. We present the first report of normal short term respiratory outcomes as measured by spirometry in children with SARS-COV-2 antibody positive, PIMS-TS syndrome managed at a specialist children’s hospital in the UK.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.